Advanced prostate cancer
An option for selected patients after other treatments, when disease shows PSMA uptake on a scan.
Prostate Cancer Theranostics
Prostate Cancer Theranostics in Gurugram.
PSMA-targeted radionuclide therapy for prostate cancer.
Targeted radionuclide therapy for selected patients with advanced prostate cancer, planned after PSMA PET-CT and reviewed together with your oncology team.
With Dr. Noaline Sinha, Nuclear Medicine & Radiotheranostics.
Artemis Hospital, Sector 51, Gurugram
About Prostate Cancer Theranostics
See the target,then treat it.
Many prostate cancer cells carry PSMA on their surface. A PSMA PET-CT shows where it is present, and a PSMA-targeted therapy carries a radioactive element to the same cells. Using the same target to image and treat is the idea behind theranostics.
Imaging first
A PSMA PET-CT helps show whether disease carries the target and whether PSMA-targeted therapy may be suitable.
Beta and alpha therapy
¹⁷⁷Lu-PSMA is a beta-emitting therapy, and ²²⁵Ac-PSMA is an alpha-emitting therapy. Which, if either, is appropriate depends on your situation.
Availability of each therapy depends on eligibility and applicable approvals, and is decided together with your oncology team.
Have a question?
Share your details and our team will get in touch.
Therapies Included
Therapies offered.
Suitability is assessed for each patient after evaluation. This list is provided for patients and for referring clinicians.
Prostate Cancer Theranostics
2 therapies
- ¹⁷⁷Lu-PSMA Targeted Radionuclide Therapy
- ²²⁵Ac-PSMA Targeted Alpha Therapy
When It May Help
Supporting treatment of advanced prostate cancer.
Your oncologist or urologist recommends treatment based on your diagnosis and clinical needs.
PSMA PET-CT planning
Scans help show whether and where disease carries the target, to plan whether therapy may be suitable.
Monitoring blood counts & kidneys
Blood tests are reviewed before and between treatments.
Reviewing response
PSA levels, scans and symptoms are reviewed together with your oncology team.
Your Visit, Step by Step
Know what to expect. Feel more prepared.
How your PSMA therapy is planned, given and followed up.
- 01
Evaluation
The team reviews your reports, history and treatment so far.
- 02
Diagnostic scan
A scan may be needed to confirm that the therapy is suitable.
- 03
Planning & therapy
The treatment is planned and given, with safety guidance for afterwards.
- 04
Follow-up
Your response is reviewed and next steps are shared with your doctor.
The exact process depends on your condition and the therapy planned.
Before Your Visit
Preparing for your visit.Simple steps.
What to discuss with the team
Your reports & scans
Bring histology, PSA results, previous treatment records and recent PSMA PET-CT reports and images.
Blood tests
Blood count, kidney and liver results are reviewed before treatment, so bring recent reports and follow the test schedule given to you.
Current prostate cancer treatment
Continue your current medicines unless your doctor advises otherwise, and tell the team about all treatments you are having.
Dry mouth & hydration
Some patients notice a dry mouth after PSMA therapy. The team will explain what to expect and how to look after yourself.
Pregnancy, breastfeeding & allergies
Let the team know before your appointment.
Guidance tailored to you
Preparation varies by therapy and by patient. Contact the team if you are unsure about any instruction.
For Referring Clinicians
Referring a patient for therapy.
A short guide for referring doctors.
- 1
What to include
The diagnosis, histology, treatment history, recent blood reports and previous imaging, so suitability can be assessed.
- 2
Evaluation first
Therapy is considered only after a clinical review and, where needed, a diagnostic scan to confirm that it is appropriate.
- 3
Coordinated care
Treatment is planned with the referring team, and follow-up findings are shared with you.
- 4
Discussing a case first
Call or write before referring if you would like to discuss suitability or timing.
Questions before you refer? Contact Dr. Sinha directly.
Your consultant
ConsultDr. Noaline Sinha.
Chairperson of the Department of Nuclear Medicine & Radiotheranostics, with over 25 years in molecular imaging and radionuclide therapy.
Experience
Over 25 years in nuclear medicine, leading the Department of Nuclear Medicine & Radiotheranostics.
Radiation safety
Certified Radiation Safety Officer (RSO-II) by the Atomic Energy Regulatory Board.
Collaborative practice
Works alongside referring and treating clinicians on every case.
Dr. Noaline Sinha
Chairperson, Nuclear Medicine & Radiotheranostics
FAQs
Common questionsabout PSMA therapy.
Answers to questions patients and families often ask before PSMA-targeted therapy.
Still have questions?Speak to our team for guidance before your visit.
No. It is considered for selected patients, usually based on a PSMA PET-CT, blood tests, previous treatment and general health. The decision is made together with your oncology team.
It shows whether disease carries the PSMA target, which helps decide whether PSMA-targeted therapy may be suitable.
¹⁷⁷Lu-PSMA emits beta radiation and ²²⁵Ac-PSMA emits alpha radiation. Which, if either, is appropriate depends on your situation, and availability depends on eligibility and approvals.
For a period after treatment your body will contain some radioactivity, so you will be given written guidance, particularly about close contact with children and pregnant women. The team will explain what applies to you.
They can include tiredness, dry mouth, nausea and changes in blood counts. The team will explain the possible effects and when to contact them.
More Services
Explore our other services.
Imaging and therapy services offered by the department.
Oncology & Molecular Imaging
Neurological PET-CT
Cardiac PET-CT
Infection, Inflammation & Skeletal Imaging- Cardiac Nuclear Medicine
- Neurological Imaging
Skeletal Imaging
Renal & Genitourinary Imaging
Hepatobiliary & Gastrointestinal Imaging
Endocrine Imaging
Pulmonary Imaging- Infection, Lymphatic & Other Imaging
- Radioiodine Therapy
Peptide Receptor Radionuclide Therapy (PRRT)
Other Targeted Radionuclide Therapies- Therapy Planning, Imaging & Dosimetry
Request an Appointment
Fill in your details and our team will get back to you to confirm your appointment.
Take the Next Step
Let’s Begin Your Journey to Better Care.
Reach out to schedule a personalised consultation or speak with our team. We’re here to guide you with clarity, compassion, and expert care — every step of the way.
Book a Consultation
Schedule a personalised consultation with Dr. Noaline Sinha at your convenience.
Talk to Our Team
Have questions? Our care team is here to help you with guidance and information.
Consult in Gurugram
Consultations are held in person in Gurugram. The team will confirm the details with you.